Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Cindy L. Berman"'
Autor:
Zhanna Sobol, Catherine C. Priestley, Michael J. Schlosser, Kevin S. Sweder, Scott A Barros, Frederick B. Oleson, Cindy L Berman, Peter Kasper, Sheila M. Galloway
Publikováno v:
Nucleic Acid Therapeutics. 26:73-85
The Oligonucleotide Safety Working Group subcommittee on genotoxicity testing considers therapeutic oligonucleotides (ONs) unlikely to be genotoxic based on their properties and on the negative results for ONs tested to date. Nonetheless, the subcomm
Autor:
Michael J. Schlosser, Sheila M. Galloway, Kevin S. Sweder, Peter Kasper, Catherine C. Priestley, Zhanna Sobol, Cindy L Berman, Scott A. Barros, Frederick B. Oleson
Publikováno v:
Oligonucleotide-Based Drugs and Therapeutics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::907bbe5528a0d99d2f4f0a47f209eca4
https://doi.org/10.1002/9781119070153.ch10
https://doi.org/10.1002/9781119070153.ch10
Autor:
Tacey E.K. White, Joy Cavagnaro, Cindy L. Berman, Sarah Campion, Scott P. Henry, Doug Kornbrust
Publikováno v:
Nucleic Acid Therapeutics. 24:313-325
This white paper summarizes the current consensus of the Reproductive Subcommittee of the Oligonucleotide Safety Working Group on strategies to assess potential reproductive and/or developmental toxicities of therapeutic oligonucleotides (ONs). The u
Autor:
Rosanne Seguin, Cindy L. Berman, Jeff Tepper, Scott P. Henry, Douglas J. Kornbrust, Joy Cavagnaro
Publikováno v:
Nucleic acid therapeutics. 26(4)
This article provides an overview of the discussions held by the Immunomodulatory Subcommittee of the Oligonucleotide Safety Working Group on complement activation induced by oligonucleotides, most notably the phosphorothioate-containing oligonucleot
Autor:
Lawrence L. Charity, Alan F. Scott, Eva K. Pressman, Cindy L. Berman, Gail Stetten, Laura Kasch, Karin J. Blakemore
Publikováno v:
American Journal of Medical Genetics. 68:76-81
We report on a de novo constitutional rearrangement involving the long arm of chromosome 7 in a second trimester fetus with the karyotype of 46,XX, inv dup del (7)(pter-q36::q36-q21.2:) pat. Both a large duplication (q21.2-q36) and a small deletion (
Autor:
Cindy L. Berman, Dave Schubert, Stephen B. Shrewsbury, Nicolay Ferrari, Arthur A. Levin, Joy Cavagnaro, Rosanne Seguin, Scott P. Henry, Doug Kornbrust
Publikováno v:
Nucleic acid therapeutics. 22(4)
YA is needed for proper nuclear organization to transition between meiosis and mitosis in Drosophila
Publikováno v:
BMC Developmental Biology
BMC Developmental Biology, Vol 9, Iss 1, p 43 (2009)
BMC Developmental Biology, Vol 9, Iss 1, p 43 (2009)
Background The Drosophila YA protein is required to initiate the embryonic cleavage divisions. After egg activation, YA enters nuclei and interacts with chromatin and the nuclear lamina. This study was designed to define more precisely the events pri
Autor:
Francis P. Tally, Claudio Carini, Michael L Zeckel, Frederick B. Oleson, Cindy L Berman, Margaret M Wasilewski, George L Drusano
Publikováno v:
Expert opinion on investigational drugs. 8(8)
The alarming increase in the incidence of Gram-positive infections, including those caused by resistant bacteria, has sparked renewed interest in novel antibiotics. One such agent is daptomycin, a novel lipopeptide antibiotic with proven bactericidal
Publisher Summary This chapter discusses the purification of platelet activation-dependent granule to external membrane (PADGEM) glycoprotein. The enzyme-linked immunosorbent assay (ELISA) is primarily used for identifying murine antiplatelet antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c13e349ff437834cf9f4af8684c74ec
https://doi.org/10.1016/0076-6879(89)69071-4
https://doi.org/10.1016/0076-6879(89)69071-4
Autor:
Berman, Cindy L., Antonsson, Madeleine, Batkai, Sandor, Bosgra, Sieto, Chopda, Girish R., Driessen, Wouter, Foy, Jeffrey, Hassan, Chopie, Hu, Xiao Shelley, Jang, Hyun Gyung, Meena, Sanseverino, Mark, Thum, Thomas, Wang, Yanfeng, Wild, Martin, Wu, Jing-Tao
Publikováno v:
Nucleic Acid Therapeutics; Oct2023, Vol. 33 Issue 5, p287-305, 19p